Search Results - "Bennani, N"

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium by Nastoupil, Loretta J, Jain, Michael D, Feng, Lei, Spiegel, Jay Y, Ghobadi, Armin, Lin, Yi, Dahiya, Saurabh, Lunning, Matthew, Lekakis, Lazaros, Reagan, Patrick, Oluwole, Olalekan, McGuirk, Joseph, Deol, Abhinav, Sehgal, Alison R, Goy, Andre, Hill, Brian T, Vu, Khoan, Andreadis, Charalambos, Munoz, Javier, Westin, Jason, Chavez, Julio C, Cashen, Amanda, Bennani, N Nora, Rapoport, Aaron P, Vose, Julie M, Miklos, David B, Neelapu, Sattva S, Locke, Frederick L

“…Axicabtagene ciloleucel (axi-cel) is an autologous CD19-directed chimeric antigen receptor (CAR) T-cell therapy approved for relapsed/refractory large B-cell…”
Get full text

Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms by Jiang, Manli, Bennani, N Nora, Feldman, Andrew L

“…Lymphomas are classified based on the normal counterpart, or cell of origin, from which they arise. Because lymphocytes have physiologic immune functions that…”
Get more information

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma by Oishi, Naoki, Hundal, Tanya, Phillips, Jessica L, Dasari, Surendra, Hu, Guangzhen, Viswanatha, David S, He, Rong, Mai, Ming, Jacobs, Hailey K, Ahmed, Nada H, Syrbu, Sergei I, Salama, Youssef, Chapman, Jennifer R, Vega, Francisco, Sidhu, Jagmohan, Bennani, N Nora, Epstein, Alan L, Medeiros, L Jeffrey, Clemens, Mark W, Miranda, Roberto N, Feldman, Andrew L

“…Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently characterized T-cell malignancy that has raised significant patient safety…”
Get full text

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease by Goyal, Gaurav, Ravindran, Aishwarya, Young, Jason R, Shah, Mithun V, Bennani, N Nora, Patnaik, Mrinal M, Nowakowski, Grzegorz S, Thanarajasingam, Gita, Habermann, Thomas M, Vassallo, Robert, Sher, Taimur, Parikh, Sameer A, Rech, Karen L, Go, Ronald S

“…Rosai-Dorfman disease is a rare subtype of non-Langerhans cell histiocytosis. With the last major report published in 1990, there is a paucity of contemporary…”
Get full text

How to Sequence Therapies in Peripheral T Cell Lymphoma by Wudhikarn, Kitsada, Bennani, N. Nora

“…Opinion statement Peripheral T cell lymphoma (PTCL) represents a heterogeneous group of rare lymphoproliferative disorders. Historically, there has been a lack…”
Get full text

Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018 by Castellino, Alessia, Pulido, Jose S., Johnston, Patrick B., Ristow, Kay M., Nora Bennani, N., Inwards, David J., Macon, William R., Micallef, Ivana N. M., King, Rebecca L., Salomao, Diva R., Witzig, Thomas E., Habermann, Thomas M., Nowakowski, Grzegorz S.

“…Vitreoretinal lymphoma (VRL) management remains a challenge. We present 72 patients with VRL, diagnosed at Mayo Clinic between 1990‐2018. Three nondiffuse…”
Get full text

Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract by Sharma, Ayush, Oishi, Naoki, Boddicker, Rebecca L., Hu, Guangzhen, Benson, Hailey K., Ketterling, Rhett P., Greipp, Patricia T., Knutson, Darlene L., Kloft-Nelson, Sara M., He, Rong, Eckloff, Bruce W., Jen, Jin, Nair, Asha A., Davila, Jaime I., Dasari, Surendra, Lazaridis, Konstantinos N., Bennani, N. Nora, Wu, Tsung-Teh, Nowakowski, Grzegorz S., Murray, Joseph A., Feldman, Andrew L.

Get full text

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study by Pedersen, Martin Bjerregård, Hamilton-Dutoit, Stephen Jacques, Bendix, Knud, Ketterling, Rhett P., Bedroske, Patrick P., Luoma, Ivy M., Sattler, Christopher A., Boddicker, Rebecca L., Bennani, N.Nora, Nørgaard, Peter, Møller, Michael Boe, Steiniche, Torben, d'Amore, Francesco, Feldman, Andrew L.

Get full text

Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet? by Macapagal, Sharina C., Bennani, N. Nora

“…Peripheral T-cell lymphomas (PTCLs) are a diverse and uncommon type of lymphoid malignancies with a dismal prognosis. Recent advances in genomic studies have…”
Get full text

Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy by Bennani, N.N., Bennani-Baiti, I.M.

Get full text

Genetic subtyping of breast implant–associated anaplastic large cell lymphoma by Oishi, Naoki, Brody, Garry S., Ketterling, Rhett P., Viswanatha, David S., He, Rong, Dasari, Surendra, Mai, Ming, Benson, Hailey K., Sattler, Christopher A., Boddicker, Rebecca L., McPhail, Ellen D., Bennani, N. Nora, Harless, Christin A., Singh, Kuldeep, Clemens, Mark W., Medeiros, L. Jeffrey, Miranda, Roberto N., Feldman, Andrew L.

Get full text

Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression by Bennani, N Nora, Kim, Hyo Jin, Pederson, Levi D, Atherton, Pamela J, Micallef, Ivana N, Thanarajasingam, Gita, Nowakowski, Grzegorz S, Witzig, Thomas, Feldman, Andrew L, Ansell, Stephen M

“…Peripheral T-cell lymphomas (PTCL), a heterogeneous group of mature aggressive non-Hodgkin’s lymphomas, carry a worse prognosis for most subtypes when compared…”
Get full text

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy by Spiegel, Jay Y., Dahiya, Saurabh, Jain, Michael D., Tamaresis, John, Nastoupil, Loretta J., Jacobs, Miriam T., Ghobadi, Armin, Lin, Yi, Lunning, Matthew, Lekakis, Lazaros, Reagan, Patrick, Oluwole, Olalekan, McGuirk, Joseph, Deol, Abhinav, Goy, Andre, Vu, Khoan, Andreadis, Charalambos, Munoz, Javier, Bennani, N. Nora, Vose, Julie M., Dorritie, Kathleen A., Neelapu, Sattva S., Locke, Frederick L., Rapoport, Aaron P., Hill, Brian T., Miklos, David B.

Get full text

Mimics of Erdheim–Chester disease by Abeykoon, Jithma P., Ravindran, Aishwarya, Rech, Karen L., Young, Jason R., Oliver Tobin, W., Shah, Mithun V., Nora Bennani, N., Vassallo, Robert, Ryu, Jay H., Koster, Matthew J., Davidge‐Pitts, Caroline J., Goyal, Gaurav, Go, Ronald S.

“…Summary Erdheim–Chester disease (ECD) is a rare histiocytic neoplasm with frequent multiorgan involvement. An accurate diagnosis of ECD requires the…”
Get full text

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease by Goyal, Gaurav, Young, Jason R., Koster, Matthew J., Tobin, W. Oliver, Vassallo, Robert, Ryu, Jay H., Davidge-Pitts, Caroline J., Hurtado, Maria D., Ravindran, Aishwarya, Sartori Valinotti, Julio C., Bennani, N. Nora, Shah, Mithun V., Rech, Karen L., Go, Ronald S.

“…Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman…”
Get full text

Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms by Goyal, Gaurav, Ravindran, Aishwarya, Liu, Yuanhang, He, Rong, Shah, Mithun V, Bennani, N Nora, Patnaik, Mrinal M, Rech, Karen L, Go, Ronald S

Get full text

Theoretical study of new conjugated compounds with a low bandgap for bulk heterojunction solar cells: DFT and TD-DFT study by Raftani, M., Abram, T., Bennani, N., Bouachrine, M.

“…Bulk heterojunction solar cells have attracted scientific and economic interest in recent years, and have just been one of the future photovoltaic technologies…”
Get full text

Primary cutaneous gamma/delta T‐cell lymphoma with simultaneous JAK2 and TP63 rearrangements: a new double‐hit? by Fadl, Amr, Bennani, N Nora, Comfere, Nneka, Durani, Urshila, Greipp, Patricia T, Feldman, Andrew L

Get full text

International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma by Maurer, Matthew J, Ellin, Fredrik, Srour, Line, Jerkeman, Mats, Bennani, N Nora, Connors, Joseph M, Slack, Graham W, Smedby, Karin E, Ansell, Stephen M, Link, Brian K, Cerhan, James R, Relander, Thomas, Savage, Kerry J, Feldman, Andrew L

“…Purpose Peripheral T-cell lymphomas (PTCLs) have aggressive clinical behavior. We have previously shown that event-free survival (EFS) at 24 months (EFS24) is…”
Get full text

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements by Luchtel, Rebecca A., Dasari, Surendra, Oishi, Naoki, Pedersen, Martin Bjerregård, Hu, Guangzhen, Rech, Karen L., Ketterling, Rhett P., Sidhu, Jagmohan, Wang, Xueju, Katoh, Ryohei, Dogan, Ahmet, Kip, N. Sertac, Cunningham, Julie M., Sun, Zhifu, Baheti, Saurabh, Porcher, Julie C., Said, Jonathan W., Jiang, Liuyan, Hamilton-Dutoit, Stephen Jacques, Møller, Michael Boe, Nørgaard, Peter, Bennani, N. Nora, Chng, Wee-Joo, Huang, Gaofeng, Link, Brian K., Facchetti, Fabio, Cerhan, James R., d'Amore, Francesco, Ansell, Stephen M., Feldman, Andrew L.

“…Anaplastic large cell lymphomas (ALCLs) are CD30-positive T-cell non-Hodgkin lymphomas broadly segregated into ALK-positive and ALK-negative types. Although…”
Get full text